Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Richard Possemato(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Kıvanç Birsoy(Rockefeller University), Franziska K. Lorbeer(Whitehead Institute for Biomedical Research), Clary B. Clish(Broad Institute), Prathapan Thiru(Whitehead Institute for Biomedical Research), Erol C. Bayraktar(Cleveland Clinic), Burcu Yücel(Whitehead Institute for Biomedical Research), Timothy C. Wang(Columbia University), Walter W. Chen(Southwestern Medical Center), David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry)
DSpace@MIT (Massachusetts Institute of Technology)
March 1, 2014
Cited by 0
Related Papers
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
mTOR signaling at a glance
|Journal of Cell Science|2009|2.1k
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
|The EMBO Journal|2012|1.9k